{"nct_id":"NCT02006485","title":"Ublituximab in Combination With TGR-1202 +/- Ibrutinib or Bendamustine in Patients With B-cell Malignancies","status":"COMPLETED","status_verified_date":"2019-11","start_date":"2013-12-13","start_date_type":"ACTUAL","primary_completion_date":"2019-10","primary_completion_date_type":"ACTUAL","completion_date":"2019-10","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TGTX"]}